Protalix BioTherapeutics (PLX) Revenue Growth (1y) (2011 - 2026)
Protalix BioTherapeutics (PLX) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 35.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Protalix BioTherapeutics | 190.95 Mn | 180.16 Mn | 29.62 Mn | 233.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 233.73% |
| Dec 31, 2025 | -49.93% |
| Sep 30, 2025 | -0.60% |
| Jun 30, 2025 | 16.21% |
| Mar 31, 2025 | 169.82% |
| Dec 31, 2024 | 73.74% |
| Sep 30, 2024 | 73.60% |
| Jun 30, 2024 | -61.59% |
| Mar 31, 2024 | -60.91% |
| Dec 31, 2023 | 21.69% |
| Sep 30, 2023 | -27.06% |
| Jun 30, 2023 | 300.72% |
| Mar 31, 2023 | -40.39% |
| Dec 31, 2022 | 0.80% |
| Sep 30, 2022 | 17.66% |
| Jun 30, 2022 | 36.19% |
| Mar 31, 2022 | 42.09% |
| Dec 31, 2021 | -56.15% |
| Sep 30, 2021 | 11.71% |
| Jun 30, 2021 | -41.40% |